-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
BioNexus Gene Lab Corp quarterly and annual Return On Equity history and change rate from Q3 2019 to Q3 2025.
- BioNexus Gene Lab Corp Return On Equity for the quarter ending 30 Sep 2025 was -30%, a 204% decline year-over-year.
- BioNexus Gene Lab Corp annual Return On Equity for 2024 was -17%, a 49% increase from 2023.
- BioNexus Gene Lab Corp annual Return On Equity for 2023 was -34%, a 549% decline from 2022.
- BioNexus Gene Lab Corp annual Return On Equity for 2022 was -5.3%, a 149% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)